Yoichiro Ichikawa
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Cystic Fibrosis Research Advances
- Respiratory and Cough-Related Research
-
- Sarcoidosis and Beryllium Toxicity Research
- Asthma and respiratory diseases
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Respiratory and Cough-Related Research 6
- Medical Imaging and Pathology Studies 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Respiratory Support and Mechanisms 3
- Tracheal and airway disorders 3
- Co-authors
- Masaharu KinoshitaKōtaro ŌizumiTakafumi YanoMasako TanakaHideyuki KogaKiminori FujimotoNaofumi HayabuchiNaoto Tokunaga
- Journals
- CHEST Journal (3 papers)International Journal of Molecular Sciences (2 papers)Chemotherapy (2 papers)Veterinary Sciences (1 paper)Journal of Clinical Medicine (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Yoichiro Ichikawa
40 papers receiving 474 citations
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 294
- Physiology 128
- Microbiology 24
- Epidemiology 107
- Rheumatology 43
Countries citing papers authored by Yoichiro Ichikawa
This map shows the geographic impact of Yoichiro Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Ichikawa more than expected).
Fields of papers citing papers by Yoichiro Ichikawa
This network shows the impact of papers produced by Yoichiro Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Ichikawa. The network helps show where Yoichiro Ichikawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Yoichiro Ichikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2008 | 5 | |
| 7 | 1995 | 12 | |
| 8 | 1995 | 6 | |
| 9 | Clinical studies of tazobactam/piperacillin in respiratory tract infections | 1994 | 2 |
| 10 | 1994 | 0 | |
| 11 | 1994 | 89 | |
| 12 | 1994 | 5 | |
| 13 | 1994 | 4 | |
| 14 | 1993 | 3 | |
| 15 | 1993 | 1 | |
| 16 | 1993 | 35 | |
| 17 | 1993 | 47 | |
| 18 | 1992 | 2 | |
| 19 | 1991 | 3 | |
| 20 | Clinical studies of TA-058 in respiratory tract infections | 1984 | 1 |
About Yoichiro Ichikawa
Yoichiro Ichikawa is a scholar working on Pulmonary and Respiratory Medicine, Ophthalmology, Applied Microbiology and Biotechnology, Infectious Diseases and Microbiology, having authored 44 papers that have together received 497 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Respiratory and Cough-Related Research (6 papers), Medical Imaging and Pathology Studies (5 papers), Pneumonia and Respiratory Infections (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Respiratory Support and Mechanisms (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Tracheal and airway disorders (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (294 citations), Physiology (128 citations), Microbiology (24 citations), Epidemiology (107 citations) and Rheumatology (43 citations). Yoichiro Ichikawa has collaborated with scholars based in Japan and United States. Frequent co-authors include Masaharu Kinoshita, Kōtaro Ōizumi, Takafumi Yano, Masako Tanaka, Hideyuki Koga, Kiminori Fujimoto, Naofumi Hayabuchi, Naoto Tokunaga, Manabu Mochizuki and Takeharu Koga. Their work appears in journals such as CHEST Journal, International Journal of Molecular Sciences, Chemotherapy, Veterinary Sciences and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.